Show simple item record

Files in this item


Item metadata

dc.contributor.authorFarhoudian, Ali
dc.contributor.authorBaldacchino, Alexander Mario
dc.contributor.authorClark, Nicolas
dc.contributor.authorGerra, Gilberto
dc.contributor.authorEkhtiari, Hamed
dc.contributor.authorDom, Geert
dc.contributor.authorMokri, Azarakhsh
dc.contributor.authorSadeghi, Mandana
dc.contributor.authorNematollahi, Pardris
dc.contributor.authorDemasi, Maryanne
dc.contributor.authorSchütz, Christian G.
dc.contributor.authorHashemian, Seyed Mohammadreza
dc.contributor.authorTabarsi, Payam
dc.contributor.authorGalea-Singer, Susanna
dc.contributor.authorCarrà, Giuseppe
dc.contributor.authorClausen, Thomas
dc.contributor.authorKouimtsidis, Christos
dc.contributor.authorTolomeo, Serenella
dc.contributor.authorRadfar, Seyed Ramin
dc.contributor.authorRazaghi, Emran Mohammed
dc.identifier.citationFarhoudian , A , Baldacchino , A M , Clark , N , Gerra , G , Ekhtiari , H , Dom , G , Mokri , A , Sadeghi , M , Nematollahi , P , Demasi , M , Schütz , C G , Hashemian , S M , Tabarsi , P , Galea-Singer , S , Carrà , G , Clausen , T , Kouimtsidis , C , Tolomeo , S , Radfar , S R & Razaghi , E M 2020 , ' COVID-19 and substance use disorders : Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paper ' , Basic and Clinical Neuroscience , vol. Special Issue on COVID-19 , pp. 129-146 .
dc.identifier.otherPURE: 267395171
dc.identifier.otherPURE UUID: 7a88aae1-b1dc-4660-ab29-c833c99786ce
dc.identifier.otherScopus: 85085038286
dc.identifier.otherWOS: 000548578800002
dc.description.abstractCoronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).
dc.relation.ispartofBasic and Clinical Neuroscienceen
dc.rightsCopyright © 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution NonCommercial License, which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.en
dc.subjectCoronavirus disease 2019 (COVID-19)en
dc.subjectPublic healthen
dc.subjectSubtance use disorderen
dc.subjectAddiction medicineen
dc.subjectHarm reductionen
dc.subjectOpioid substitution therapyen
dc.subjectRA0421 Public health. Hygiene. Preventive Medicineen
dc.subjectRC0321 Neuroscience. Biological psychiatry. Neuropsychiatryen
dc.subjectRM Therapeutics. Pharmacologyen
dc.titleCOVID-19 and substance use disorders : Recommendations to a comprehensive healthcare response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group position paperen
dc.typeJournal itemen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews.School of Medicineen
dc.contributor.institutionUniversity of St Andrews.Centre for Minorities Research (CMR)en
dc.contributor.institutionUniversity of St Andrews.Population and Behavioural Science Divisionen
dc.description.statusPeer revieweden

This item appears in the following Collection(s)

Show simple item record